Published in Front Hum Neurosci on April 10, 2013
Role of the sensorimotor cortex in Tourette syndrome using multimodal imaging. Hum Brain Mapp (2014) 0.90
The role of alpha-rhythm states in perceptual learning: insights from experiments and computational models. Front Comput Neurosci (2014) 0.90
Discrimination of cortical laminae using MEG. Neuroimage (2014) 0.86
Alpha band functional connectivity correlates with the performance of brain-machine interfaces to decode real and imagined movements. Front Hum Neurosci (2014) 0.76
Alpha-band EEG activity in perceptual learning. J Vis (2015) 0.75
Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex. PLoS One (2017) 0.75
Neurophysiological investigation of the basis of the fMRI signal. Nature (2001) 23.94
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature (1995) 7.75
Dynamic statistical parametric mapping: combining fMRI and MEG for high-resolution imaging of cortical activity. Neuron (2000) 5.97
Coupling between neuronal firing rate, gamma LFP, and BOLD fMRI is related to interneuronal correlations. Curr Biol (2007) 4.35
A mechanism for generation of long-range synchronous fast oscillations in the cortex. Nature (1996) 4.03
Coherent 25- to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys. Proc Natl Acad Sci U S A (1992) 4.02
Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci U S A (2009) 3.31
Signal processing in magnetoencephalography. Methods (2001) 3.20
Spatiotemporal characteristics of sensorimotor neuromagnetic rhythms related to thumb movement. Neuroscience (1994) 3.14
Coherent oscillations in monkey motor cortex and hand muscle EMG show task-dependent modulation. J Physiol (1997) 2.92
Investigating the electrophysiological basis of resting state networks using magnetoencephalography. Proc Natl Acad Sci U S A (2011) 2.69
A beta2-frequency (20-30 Hz) oscillation in nonsynaptic networks of somatosensory cortex. Proc Natl Acad Sci U S A (2006) 2.26
A new approach to neuroimaging with magnetoencephalography. Hum Brain Mapp (2005) 2.21
Spatiotemporal imaging of human brain activity using functional MRI constrained magnetoencephalography data: Monte Carlo simulations. Proc Natl Acad Sci U S A (1998) 2.10
Natural frequencies of human corticothalamic circuits. J Neurosci (2009) 2.07
Spatiotemporal mapping of brain activity by integration of multiple imaging modalities. Curr Opin Neurobiol (2001) 1.94
Post-movement beta rebound is generated in motor cortex: evidence from neuromagnetic recordings. Neuroimage (2006) 1.94
Foot and hand area mu rhythms. Int J Psychophysiol (1997) 1.87
On the human sensorimotor-cortex beta rhythm: sources and modeling. Neuroimage (2005) 1.77
Rolandic alpha and beta EEG rhythms' strengths are inversely related to fMRI-BOLD signal in primary somatosensory and motor cortex. Hum Brain Mapp (2009) 1.70
Task-related changes in cortical synchronization are spatially coincident with the hemodynamic response. Neuroimage (2002) 1.68
Baseline GABA concentration and fMRI response. Neuroimage (2010) 1.59
Relating MEG measured motor cortical oscillations to resting γ-aminobutyric acid (GABA) concentration. Neuroimage (2011) 1.51
Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet (1995) 1.49
Prestimulus alpha and mu activity predicts failure to inhibit motor responses. Hum Brain Mapp (2009) 1.48
Contributions of principal neocortical neurons to magnetoencephalography and electroencephalography signals. J Physiol (2006) 1.47
The missing link: analogous human and primate cortical gamma oscillations. Neuroimage (2005) 1.42
Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. Br J Clin Pharmacol (2003) 1.40
Patterns of cortical activation during planning of voluntary movement. Electroencephalogr Clin Neurophysiol (1989) 1.38
Negative blood oxygen level dependence in the rat: a model for investigating the role of suppression in neurovascular coupling. J Neurosci (2010) 1.35
GLM-beamformer method demonstrates stationary field, alpha ERD and gamma ERS co-localisation with fMRI BOLD response in visual cortex. Neuroimage (2005) 1.35
Pharmacologically induced and stimulus evoked rhythmic neuronal oscillatory activity in the primary motor cortex in vitro. Neuroscience (2007) 1.30
The role of GABAergic modulation in motor function related neuronal network activity. Neuroimage (2011) 1.29
Induced visual illusions and gamma oscillations in human primary visual cortex. Eur J Neurosci (2004) 1.24
Realistic spatial sampling for MEG beamformer images. Hum Brain Mapp (2004) 1.19
Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalography. Hum Brain Mapp (2010) 1.17
Spatiotemporal activity of a cortical network for processing visual motion revealed by MEG and fMRI. J Neurophysiol (1999) 1.17
The effects of elevated endogenous GABA levels on movement-related network oscillations. Neuroimage (2012) 1.13
Magnetoencephalography: a tool for functional brain imaging. Brain Topogr (1992) 1.07
Relating BOLD fMRI and neural oscillations through convolution and optimal linear weighting. Neuroimage (2009) 1.07
Functional decoupling of BOLD and gamma-band amplitudes in human primary visual cortex. Hum Brain Mapp (2009) 1.06
Spatiotemporal frequency tuning of BOLD and gamma band MEG responses compared in primary visual cortex. Neuroimage (2008) 1.05
Which "neural activity" do you mean? fMRI, MEG, oscillations and neurotransmitters. Neuroimage (2012) 1.01
Event-related desynchronization in reaction time paradigms: a comparison with event-related potentials and corticospinal excitability. Clin Neurophysiol (2001) 0.97
Selectivity of human retinotopic visual cortex to S-cone-opponent, L/M-cone-opponent and achromatic stimulation. Eur J Neurosci (2007) 0.95
GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report. Clin Neurophysiol (2010) 0.92
Origins of 1/f2 scaling in the power spectrum of intracortical local field potential. J Neurophysiol (2011) 0.91
Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo. J Clin Pharmacol (2006) 0.89
Induced Gamma activity in primary visual cortex is related to luminance and not color contrast: An MEG study. J Vis (2008) 0.89
Functional stability of hippocampal slices after treatment with cyclooxygenase inhibitors. Neuroreport (1997) 0.78
The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther (2003) 3.71
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2005) 3.63
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology (2004) 3.27
Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther (2004) 1.89
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology (2003) 1.65
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol (2012) 1.58
Airflows around oxygen masks: A potential source of infection? Chest (2006) 1.53
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos (2002) 1.52
Drug interactions with herbal products and grapefruit juice: a conference report. Clin Pharmacol Ther (2004) 1.51
The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther (2004) 1.44
Exhaled air dispersion distances during noninvasive ventilation via different Respironics face masks. Chest (2009) 1.41
Tonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic rats. J Neurosci (2006) 1.40
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt. J Clin Gastroenterol (2011) 1.38
GLM-beamformer method demonstrates stationary field, alpha ERD and gamma ERS co-localisation with fMRI BOLD response in visual cortex. Neuroimage (2005) 1.35
Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther (2002) 1.28
Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole. Drug Metab Dispos (2006) 1.27
Selective metabolism of vincristine in vitro by CYP3A5. Drug Metab Dispos (2006) 1.26
Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatr Blood Cancer (2008) 1.18
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2010) 1.18
Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology (2009) 1.17
Noninvasive positive-pressure ventilation: An experimental model to assess air and particle dispersion. Chest (2006) 1.13
The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Clin Pharmacol Ther (2003) 1.13
Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci (2004) 1.13
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol (2003) 1.11
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin. Drug Metab Dispos (2009) 1.11
Drug-drug interaction prediction: a Bayesian meta-analysis approach. Stat Med (2007) 1.08
Association between the CYP3A5 genotype and blood pressure. Hypertension (2004) 1.07
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos (2002) 1.06
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes. J Pharmacol Exp Ther (2007) 1.04
Sustained neuronal activity generated by glial plasticity. J Neurosci (2011) 1.03
The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Clin Pharmacol Ther (2006) 1.02
The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition. Drug Metab Dispos (2002) 1.01
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. AIDS (2008) 0.99
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite. Drug Metab Dispos (2009) 0.99
Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression. Clin Pharmacol Ther (2005) 0.99
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity. Clin Gastroenterol Hepatol (2007) 0.99
Functional characterization of GABAergic pallidopallidal and striatopallidal synapses in the rat globus pallidus in vitro. Eur J Neurosci (2008) 0.98
Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites. Drug Metab Dispos (2004) 0.96
Computational approaches that predict metabolic intermediate complex formation with CYP3A4 (+b5). Drug Metab Dispos (2007) 0.96
Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. Biochem Pharmacol (2006) 0.95
Background synaptic activity in rat entorhinal cortical neurones: differential control of transmitter release by presynaptic receptors. J Physiol (2004) 0.95
Literature mining on pharmacokinetics numerical data: a feasibility study. J Biomed Inform (2009) 0.93
In vivo real-time 3-D intracardiac echo using PMUT arrays. IEEE Trans Ultrason Ferroelectr Freq Control (2014) 0.92
Functional presynaptic HCN channels in the rat globus pallidus. Eur J Neurosci (2007) 0.92
GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report. Clin Neurophysiol (2010) 0.92
Prediction of the effect of erythromycin, diltiazem, and their metabolites, alone and in combination, on CYP3A4 inhibition. Drug Metab Dispos (2008) 0.91
A general linear model for MEG beamformer imaging. Neuroimage (2004) 0.91
Mobility of NMDA autoreceptors but not postsynaptic receptors at glutamate synapses in the rat entorhinal cortex. J Physiol (2008) 0.90
Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients. Ann Surg (2013) 0.90
Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase. Drug Metab Dispos (2012) 0.89
Exhaled air dispersion during oxygen delivery via a simple oxygen mask. Chest (2007) 0.89
Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation. Biochem Pharmacol (2012) 0.88
Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes. Am J Gastroenterol (2005) 0.88
Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil. Drug Metab Dispos (2005) 0.88
Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab Dispos (2002) 0.88
Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology (2005) 0.87
Depression of glutamate and GABA release by presynaptic GABAB receptors in the entorhinal cortex in normal and chronically epileptic rats. Neurosignals (2007) 0.87
The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity. Br J Clin Pharmacol (2002) 0.87
A new probabilistic rule for drug-dug interaction prediction. J Pharmacokinet Pharmacodyn (2009) 0.86
Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution. J Chem Inf Model (2013) 0.86
Oscillatory beta activity mediates neuroplastic effects of motor cortex stimulation in humans. J Neurosci (2013) 0.85
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance. Drug Metab Dispos (2005) 0.85
Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control (2007) 0.85
Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses. Eur J Neurosci (2002) 0.85
Depolarisation and suppression of burst firing activity in the mouse subthalamic nucleus by dopamine D1/D5 receptor activation of a cyclic-nucleotide gated non-specific cation conductance. Neuropharmacology (2008) 0.85
Reflecting on mirror mechanisms: motor resonance effects during action observation only present with low-intensity transcranial magnetic stimulation. PLoS One (2013) 0.84
Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology (2003) 0.84
Acute administration of cocaine reduces metabotropic glutamate receptor 8 protein expression in the rat striatum in vivo. Neurosci Lett (2008) 0.84
Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Ther Drug Monit (2008) 0.84
Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest (2009) 0.83
Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia. J Alzheimers Dis (2012) 0.83
Interaction between midazolam and clarithromycin in the elderly. Br J Clin Pharmacol (2007) 0.83
Effect of cirrhosis and liver transplantation on the gender difference in QT interval. Am J Cardiol (2005) 0.83
Lamina-specific differences in GABA(B) autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex. Neuropharmacology (2004) 0.82
Optimization of drug-drug interaction study design: comparison of minimal physiologically based pharmacokinetic models on prediction of CYP3A inhibition by ketoconazole. Drug Metab Dispos (2013) 0.82
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin. Eur J Clin Pharmacol (2012) 0.82
Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes. J Pharmacol Exp Ther (2008) 0.82
Primary and secondary somatosensory cortex responses to anticipation and pain: a magnetoencephalography study. Eur J Neurosci (2011) 0.82
A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes. Proteomics (2008) 0.82
A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) models. J Biopharm Stat (2009) 0.81
Irreversible enzyme inhibition kinetics and drug-drug interactions. Methods Mol Biol (2014) 0.81
Transcranial magnetic stimulation reveals modulation of corticospinal excitability when observing actions with the intention to imitate. Eur J Neurosci (2012) 0.81
The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine. Drug Metab Dispos (2013) 0.81
Prior action execution has no effect on corticospinal facilitation during action observation. Behav Brain Res (2012) 0.81
The effect of anesthesia and surgery on CYP3A activity in rats. Drug Metab Dispos (2004) 0.81
Modulation of network oscillatory activity and GABAergic synaptic transmission by CB1 cannabinoid receptors in the rat medial entorhinal cortex. Neural Plast (2008) 0.80
CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modeling. Drug Metab Dispos (2013) 0.80
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats. Drug Metab Dispos (2010) 0.79
Ethosuximide modifies network excitability in the rat entorhinal cortex via an increase in GABA release. Neuropharmacology (2011) 0.79
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol (2009) 0.78
Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions. Drug Metab Dispos (2012) 0.78
Drug-drug interaction prediction assessment. J Biopharm Stat (2009) 0.77